tiprankstipranks
Trending News
More News >
ImageneBio (IMA)
NASDAQ:IMA
US Market
Advertisement

ImageneBio (IMA) Stock Forecast & Price Target

Compare
107 Followers
See the Price Targets and Ratings of:

IMA Financial Forecast

No data currently available

IMA Earnings Forecast

Currently, no earnings data available.
Currently, no earnings data available.
No data currently available

IMA Sales Forecast

Currently, no sales data available.
Currently, no sales data available.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
William Blair Analyst forecast on IMA
William Blair
William Blair
Buy
Reiterated
05/08/25
Analysts Offer Insights on Healthcare Companies: Ikena Oncology (NASDAQ: IKNA) and Knight Therapeutics (Other OTC: KHTRF)
TR | OpenAI - 4o Analyst forecast on IMA
TR | OpenAI - 4o
TR | OpenAI - 4o
Hold
Upgraded
05/02/25
AI Generated ArticleAI Generated Article
TR | OpenAI - 4o Analyst forecast on IMA
TR | OpenAI - 4o
TR | OpenAI - 4o
Sell
Reiterated
04/26/25
AI Generated ArticleAI Generated Article
TR | OpenAI - 4o Analyst forecast on IMA
TR | OpenAI - 4o
TR | OpenAI - 4o
Sell
Reiterated
04/21/25
AI Generated ArticleAI Generated Article
TR | OpenAI - 4o Analyst forecast on IMA
TR | OpenAI - 4o
TR | OpenAI - 4o
Sell
Downgraded
04/20/25
AI Generated ArticleAI Generated Article
TR | OpenAI - 4o Analyst forecast on IMA
TR | OpenAI - 4o
TR | OpenAI - 4o
Hold
Reiterated
03/07/25
AI Generated ArticleAI Generated Article
TR | OpenAI - 4o Analyst forecast on IMA
TR | OpenAI - 4o
TR | OpenAI - 4o
Hold
Reiterated
01/07/25
AI Generated ArticleAI Generated Article
TR | OpenAI - 4o Analyst forecast on IMA
TR | OpenAI - 4o
TR | OpenAI - 4o
Hold
Upgraded
01/05/25
AI Generated ArticleAI Generated Article
TR | OpenAI - 4o Analyst forecast on IMA
TR | OpenAI - 4o
TR | OpenAI - 4o
Sell
Reiterated
12/25/24
AI Generated ArticleAI Generated Article
TR | OpenAI - 4o Analyst forecast on IMA
TR | OpenAI - 4o
TR | OpenAI - 4o
Sell
Reiterated
12/24/24
AI Generated ArticleAI Generated Article
TR | OpenAI - 4o Analyst forecast on IMA
TR | OpenAI - 4o
TR | OpenAI - 4o
Sell
Reiterated
12/21/24
AI Generated ArticleAI Generated Article
TR | OpenAI - 4o Analyst forecast on IMA
TR | OpenAI - 4o
TR | OpenAI - 4o
Sell
Reiterated
12/20/24
AI Generated ArticleAI Generated Article
TR | OpenAI - 4o Analyst forecast on IMA
TR | OpenAI - 4o
TR | OpenAI - 4o
Sell
Reiterated
12/19/24
AI Generated ArticleAI Generated Article
TR | OpenAI - 4o Analyst forecast on IMA
TR | OpenAI - 4o
TR | OpenAI - 4o
Sell
Initiated
11/14/24
AI Generated ArticleAI Generated Article
H.C. Wainwright Analyst forecast on IMA
H.C. Wainwright
H.C. Wainwright
$4
Buy
-70.65%
Downside
Reiterated
11/11/24
Buy Rating for Ikena Oncology Driven by Promising IK-595 Developments
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
William Blair Analyst forecast on IMA
William Blair
William Blair
Buy
Reiterated
05/08/25
Analysts Offer Insights on Healthcare Companies: Ikena Oncology (NASDAQ: IKNA) and Knight Therapeutics (Other OTC: KHTRF)
TR | OpenAI - 4o Analyst forecast on IMA
TR | OpenAI - 4o
TR | OpenAI - 4o
Hold
Upgraded
05/02/25
AI Generated ArticleAI Generated Article
TR | OpenAI - 4o Analyst forecast on IMA
TR | OpenAI - 4o
TR | OpenAI - 4o
Sell
Reiterated
04/26/25
AI Generated ArticleAI Generated Article
TR | OpenAI - 4o Analyst forecast on IMA
TR | OpenAI - 4o
TR | OpenAI - 4o
Sell
Reiterated
04/21/25
AI Generated ArticleAI Generated Article
TR | OpenAI - 4o Analyst forecast on IMA
TR | OpenAI - 4o
TR | OpenAI - 4o
Sell
Downgraded
04/20/25
AI Generated ArticleAI Generated Article
TR | OpenAI - 4o Analyst forecast on IMA
TR | OpenAI - 4o
TR | OpenAI - 4o
Hold
Reiterated
03/07/25
AI Generated ArticleAI Generated Article
TR | OpenAI - 4o Analyst forecast on IMA
TR | OpenAI - 4o
TR | OpenAI - 4o
Hold
Reiterated
01/07/25
AI Generated ArticleAI Generated Article
TR | OpenAI - 4o Analyst forecast on IMA
TR | OpenAI - 4o
TR | OpenAI - 4o
Hold
Upgraded
01/05/25
AI Generated ArticleAI Generated Article
TR | OpenAI - 4o Analyst forecast on IMA
TR | OpenAI - 4o
TR | OpenAI - 4o
Sell
Reiterated
12/25/24
AI Generated ArticleAI Generated Article
TR | OpenAI - 4o Analyst forecast on IMA
TR | OpenAI - 4o
TR | OpenAI - 4o
Sell
Reiterated
12/24/24
AI Generated ArticleAI Generated Article
TR | OpenAI - 4o Analyst forecast on IMA
TR | OpenAI - 4o
TR | OpenAI - 4o
Sell
Reiterated
12/21/24
AI Generated ArticleAI Generated Article
TR | OpenAI - 4o Analyst forecast on IMA
TR | OpenAI - 4o
TR | OpenAI - 4o
Sell
Reiterated
12/20/24
AI Generated ArticleAI Generated Article
TR | OpenAI - 4o Analyst forecast on IMA
TR | OpenAI - 4o
TR | OpenAI - 4o
Sell
Reiterated
12/19/24
AI Generated ArticleAI Generated Article
TR | OpenAI - 4o Analyst forecast on IMA
TR | OpenAI - 4o
TR | OpenAI - 4o
Sell
Initiated
11/14/24
AI Generated ArticleAI Generated Article
H.C. Wainwright Analyst forecast on IMA
H.C. Wainwright
H.C. Wainwright
$4
Buy
-70.65%
Downside
Reiterated
11/11/24
Buy Rating for Ikena Oncology Driven by Promising IK-595 Developments
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering ImageneBio

1 Month
xxx
Success Rate
3/8 ratings generated profit
38%
Average Return
+4.15%
reiterated a xxx
rating 10 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 37.50% of your transactions generating a profit, with an average return of +4.15% per trade.
3 Months
xxx
Success Rate
4/8 ratings generated profit
50%
Average Return
-2.64%
reiterated a xxx
rating 10 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of -2.64% per trade.
1 Year
Andres Y. MaldonadoH.C. Wainwright
Success Rate
1/8 ratings generated profit
13%
Average Return
-24.88%
reiterated a buy rating 10 months ago
Copying Andres Y. Maldonado's trades and holding each position for 1 Year would result in 12.50% of your transactions generating a profit, with an average return of -24.88% per trade.
2 Years
xxx
Success Rate
0/8 ratings generated profit
0%
Average Return
-36.14%
reiterated a xxx
rating 10 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -36.14% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

IMA Analyst Recommendation Trends

Rating
Dec 24
Jan 25
Mar 25
Apr 25
May 25
Strong Buy
0
0
0
0
0
Buy
3
1
1
1
2
Hold
1
1
2
2
2
Sell
5
5
4
1
1
Strong Sell
0
0
0
0
0
total
9
7
7
4
5
In the current month, IMA has received 2 Buy Ratings, 2 Hold Ratings, and 1 Sell Ratings. IMA average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

IMA Stock Forecast FAQ

What is IMA’s average 12-month price target, according to analysts?
Currently, no data Available
What is IMA’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for IMA, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is IMA a Buy, Sell or Hold?
      ImageneBio has a consensus rating of Moderate Buy which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
        What is ImageneBio’s price target?
        Currently, no data Available
        What do analysts say about ImageneBio?
        ImageneBio’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 0 Wall Streets Analysts.
          How can I buy shares of IMA?
          Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis